Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
16.85
+0.83 (5.18%)
At close: Jun 26, 2026, 4:00 PM EDT
16.86
+0.01 (0.04%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Sarepta Therapeutics Employees
Sarepta Therapeutics had 835 employees as of December 31, 2025. The number of employees decreased by 537 or -39.14% compared to the previous year.
Employees
835
Change (1Y)
-537
Growth (1Y)
-39.14%
Revenue / Employee
$2,615,789
Profits / Employee
$77,913
Market Cap
1.78B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 835 | -537 | -39.14% |
| Dec 31, 2024 | 1,372 | 58 | 4.41% |
| Dec 31, 2023 | 1,314 | 152 | 13.08% |
| Dec 31, 2022 | 1,162 | 322 | 38.33% |
| Dec 31, 2021 | 840 | -26 | -3.00% |
| Dec 31, 2020 | 866 | 123 | 16.55% |
| Dec 31, 2019 | 743 | 244 | 48.90% |
| Dec 31, 2018 | 499 | 244 | 95.69% |
| Dec 31, 2017 | 255 | 58 | 29.44% |
| Dec 31, 2016 | 197 | -73 | -27.04% |
| Dec 31, 2015 | 270 | 66 | 32.35% |
| Dec 31, 2014 | 204 | 58 | 39.73% |
| Dec 31, 2013 | 146 | 43 | 41.75% |
| Dec 31, 2012 | 103 | 5 | 5.10% |
| Dec 31, 2011 | 98 | 0 | - |
| Dec 31, 2010 | 98 | 35 | 55.56% |
| Dec 31, 2009 | 63 | -20 | -24.10% |
| Dec 31, 2008 | 83 | -42 | -33.60% |
| Dec 31, 2007 | 125 | 8 | 6.84% |
| Dec 31, 2006 | 117 | -6 | -4.88% |
| Dec 31, 2005 | 123 | 11 | 9.82% |
| Dec 31, 2004 | 112 | 6 | 5.66% |
| Dec 31, 2003 | 106 | 17 | 19.10% |
| Dec 31, 2002 | 89 | 4 | 4.71% |
| Dec 31, 2001 | 85 | 14 | 19.72% |
| Dec 31, 2000 | 71 | 15 | 26.79% |
| Dec 31, 1999 | 56 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Vir Biotechnology | 367 |
| UroGen Pharma | 298 |
| Zymeworks | 243 |
| Innoviva | 159 |
| Absci | 140 |
| Septerna | 130 |
| AnaptysBio | 104 |
SRPT News
- 19 days ago - Sarepta Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Sarepta Therapeutics Transcript: AGM 2026 - Transcripts
- 26 days ago - Sarepta Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Sarepta price target lowered to $19 from $20 at Evercore ISI - TheFly
- 6 weeks ago - Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference - Business Wire
- 7 weeks ago - Sarepta reports Q1 adjusted EPS $3.16 vs ($3.42) last year - TheFly
- 7 weeks ago - Sarepta Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Sarepta Therapeutics Quarterly report: Q1 2026 - Filings